Envista Holdings Corporation (NVST)

Market Cap	3.83B
Revenue (ttm)	2.62B +4.7%
Net Income	15.30M
EPS	0.09
Shares Out	164.43M
PE Ratio	270.66
Forward PE	18.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,259,748
Open	24.17
Previous Close	24.08
Day's Range	23.20 - 24.22
52-Week Range	14.22 - 25.41
Beta	0.99
Analysts	Buy
Price Target	21.85 (-6.26%)
Earnings Date	Feb 5, 2026

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 18, 2019
• Employees: 12,300
• Stock Exchange: NYSE
• Ticker Symbol: NVST
• Website: https://envistaco.com

Financial Performance

In 2024, Envista Holdings's revenue was $2.51 billion, a decrease of -2.18% compared to the previous year's $2.57 billion. Losses were -$1.12 billion, 1016.4% more than in 2023.

Analyst Summary

According to 14 analysts, the average rating for NVST stock is "Buy." The 12-month stock price target is $21.85, which is a decrease of -6.26% from the latest price.

Price Target

$21.85

(-6.26% downside)

Analyst Consensus: Buy